| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.12 | 0.009 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.092 | 0.009 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.16 | 0.01 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.097 | 0.02 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |